Delivery Order SPE2DB20D3103-SPE2DB22FL5M2

Award Date 11/2/21
Potential Completion Date 11/3/21
Potential Value $10K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the supply of Trulicity 0.75 mg/0.5 ml pens. The $4,445.83 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which runs through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is for the delivery of Trulicity 1.5 mg/0.5 ml pens. The contract, valued at $3,204.20, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 26, 2021. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 0.75 mg/0.5 ml pens. The $9,820.87 firm-fixed-price delivery order has a completion date of May 2, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which enables the efficient procurement of a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,788.84 firm-fixed-price delivery order is for the procurement of Trulicity 0.75 mg/0.5 ml pens. This award is under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 through November 2026. The IDC enables efficient government acquisition of a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $3,382.32 for the delivery of Trulicity 0.75 mg/0.5 ml medication pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 15, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 1.5 mg/0.5 ml pens. The Firm Fixed Price contract, valued at $9,470.63, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Trulicity 0.75 mg/0.5 ml pens with a ceiling value of $5,660.46. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 5, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract has a ceiling value of $7,208.64 and an ultimate completion date of May 3, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $4,355.84, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical through December 2025. The IDC serves as the primary vehicle for Cencora, Inc. to provide a wide range of...
This federal contract award, valued at $10,740.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens with a completion date of August 15, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FL5M2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pens. The $10,080.00 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials, to support military treatment facilities and veteran healthcare programs worldwide. The contract award did not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 11:49 AM